FOLLOW-UP STUDY ON THE ANTIBODY RESPONSE TO HEPATITIS B, ACELLULAR PERTUSSIS TOXIN AND INACTIVATED POLIOVIRUS ANTIGENS 1 MONTH AFTER THE 4TH HEXAVAC® VACCINATION IN HEALTHY CHILDREN, WHO PARTICIPATED IN NEISVAC-C STUDY 216: